Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study Article

sustainable development goals

authors

publication date

  • May 1, 2015

webpage

published in

keywords

  • Dehydroepiandrosterone
  • Local action
  • Prasterone
  • Secondary symptomatology
  • Vulvovaginal atrophy

start page

  • 46

end page

  • 56

volume

  • 81

issue

  • 1